- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Sustainable Track Record
Global Pharmaceuticals & Biotech Sustainable Track Record
Results
56
4 new
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
56 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
524742 | ₹1,915.65 | -13.6% | 21.7% | ₹145.6b | ₹2,470.00 | PE28.3x | E13.6% | 0.3% | ||
AMPH | US$31.02 | -4.2% | -42.6% | US$1.5b | US$44.40 | PE9.5x | E5.6% | n/a | ||
FIDSON | ₦20.00 | -4.3% | 19.0% | ₦45.9b | ₦22.58 | PE9.1x | n/a | 5.0% | ||
6472 | NT$905.00 | 6.0% | 40.3% | NT$93.5b | NT$1,018.83 | PE24x | E17.1% | 1.3% | ||
BETA | ₹1,779.40 | -5.2% | 32.1% | ₹17.1b | n/a | PE41.7x | n/a | n/a | ||
HINOON | PK₨857.16 | -2.4% | 81.9% | PK₨45.4b | n/a | PE15x | n/a | 3.5% | ||
NOVO B | DKK 557.50 | -11.4% | -34.5% | DKK 2.5t | DKK 813.17 | PE24.5x | E12.8% | 2.0% | ||
PHAR | ج.م45.56 | 1.4% | -1.8% | ج.م6.8b | ج.م77.62 | PE5.8x | E21.7% | 2.2% |